BridgeMD
New treatment option for Cancer
Official title Integrated Short-Term Palliative Rehabilitation in Incurable Cancer
ClinicalTrials.gov ID: NCT05984797
What this study is testing
- What it's testing
- The goal of this intervention trial is to determine if palliative rehabilitation in addition to usual care is more effective than usual care at improving health-related quality of life in patients with incurable solid cancer.
- Time commitment: about 16 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged 18 years or older.
- Diagnosis of incurable solid cancer: lung, colorectal, breast, prostate or other, irrespective of timing in relation to any oncology or palliative...
- Eastern Cooperative Oncology Group performance status 2-3
- Able to provide informed consent and complete trial assessments in available languages.
You likely can't join if
- Blood cancers: Leukaemia, Lymphoma, Myelodysplastic Syndromes (MDS), Myeloproliferative Disorder (MPD), Multiple Myeloma.
- Currently receiving specialist rehabilitation\ for their cancer or co-morbidity-related dysfunction, or received within the two weeks prior to...
- Clinician rated prognosis of less than 3 months.
The study team makes the final eligibility decision.
Where it's taking place
- Herlev, Denmark
- Lyon, France
- Milan, Italy
- Reggio Emilia, Italy
- Trondheim, Norway
- Edinburgh, United Kingdom
- Leeds, United Kingdom
- London, United Kingdom
- Worthing, United Kingdom
- York, United Kingdom
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 16 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Herlev, Denmark; Lyon, France; Milan, Italy; Reggio Emilia, Italy; Trondheim, Norway; Edinburgh, United Kingdom and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.